Seres Therapeutics, Inc.

MCRB | NASDAQ | 1 Followers
$7.99 -0.50% -$0.04
Follow
Loading...

Profile

Seres Therapeutics, Inc. (MCRB) is a biotechnology company focused on developing microbiome-based therapies. Their research and development efforts are centered around leveraging natural bacterial communities inhabiting the human body to treat various diseases. Seres Therapeutics particularly targets areas of the gastrointestinal tract, infectious diseases, and immune disorders. The company is developing microbiome-based therapeutics aimed at restoring the health of microbial communities in patients. Their research focuses on identifying and selecting appropriate bacterial strains and their application in treating specific diseases. Shares of Seres Therapeutics, Inc. (MCRB) could be suitable for investors seeking investments in the biotechnology sector with a focus on developing innovative microbiome-based drugs.

Feed

There are no posts to show right now.
Don't have an account? Join us

Log in to Bulios


Or use email and password
Already a member? Log in

Create Bulios profile

Continue with

Or use email and password
You can use lowercase letters, numbers, and underscores

Why Bulios?

One of the fastest growing investor communities in Europe

Comprehensive data on thousands of stocks from around the world

Current information from global markets and individual companies

Education and exchange of investment experience among investors

Fair prices, portfolio tracker, stock screener and other tools

Menu StockBot
Tracker
Upgrade